GLSI

Greenwich LifeSciences, Inc.

Healthcare · USD

Set alert

Price alert · GLSI

All alert types
17.41 USD -1.59 -8.37%
As of Oct 30, 2026 Extended hours 17.41 0.00%
Bid
17.37 × 2
Ask
17.41 × 2
17.08 Day range 18.77
7.85 52-week range 33.56
YTD
-17.13%
1 year
+89.45%
Open
18.47
Prev close
19.00
Mkt cap
255.55M
Vol
174.65K
Avg vol
126.59K
EPS
-1.53
P/E
0.00
Div yield
0.00%
More statistics
Low
17.08
High
18.77
Forward P/E
-14.83
Beta
3.32
Short ratio
21.41
Inst. own
8.70%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
13.57
200-d avg
14.65
1y target
38.00

5D chart

Chart tools
Interval
GLSI five-day price chart14.816.017.118.319.5Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

3.72 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -14.7×
FY 2017: -38.5×FY 2018: -35.7×FY 2019: -17.2×FY 2020: -243×FY 2021: -69.5×FY 2022: -24.9×FY 2023: -15.2×FY 2024: -9.3×FY 2025: -14.7×
FY 2017 5y median -15.2× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 805×
FY 2017: -6.9×FY 2018: -5.9×FY 2019: -43.5×FY 2020: 16.8×FY 2021: 11.7×FY 2022: 14.9×FY 2023: 20.2×FY 2024: 161×FY 2025: 805×
FY 2017 5y median 20.2× FY 2025
P/FCF -28.7×
FY 2017: -486×FY 2018: -521×FY 2019: -200×FY 2020: -402×FY 2021: -73.4×FY 2022: -31.7×FY 2023: -20.9×FY 2024: -20.1×FY 2025: -28.7×
FY 2017 5y median -28.7× FY 2025
EV/EBITDA -14.4×
FY 2017: -37.4×FY 2018: -35.4×FY 2019: -17.3×FY 2020: -234×FY 2021: -63.0×FY 2022: -23.4×FY 2023: -14.4×FY 2024: -8.2×FY 2025: -14.4×
FY 2017 5y median -14.4× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -3.5%
FY 2017: -0.2%FY 2018: -0.2%FY 2019: -0.5%FY 2020: -0.2%FY 2021: -1.4%FY 2022: -3.2%FY 2023: -4.8%FY 2024: -5.0%FY 2025: -3.5%
FY 2017 5y median -3.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -5480.5%
FY 2017: 18.4%FY 2018: 16.7%FY 2019: 253.6%FY 2020: -6.7%FY 2021: -17.0%FY 2022: -59.2%FY 2023: -132.7%FY 2024: -1916.5%FY 2025: -5480.5%
FY 2017 5y median -132.7% FY 2025
ROIC -5505.9%
FY 2017: 296.7%FY 2018: 272.5%FY 2019: 478.9%FY 2020: -6.7%FY 2021: -17.1%FY 2022: -60.8%FY 2023: -139.2%FY 2024: -1941.1%FY 2025: -5505.9%
FY 2017 5y median -139.2% FY 2025
ROA -313.3%
FY 2017: -5805.3%FY 2018: -1556.6%FY 2019: -12842.8%FY 2020: -6.5%FY 2021: -16.8%FY 2022: -58.1%FY 2023: -127.1%FY 2024: -425.4%FY 2025: -313.3%
FY 2017 5y median -127.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -10.3%
FY 2017: 0.0%FY 2018: -7.4%FY 2019: -102.7%FY 2020: 45.6%FY 2021: -146.7%FY 2022: -74.9%FY 2023: -16.0%FY 2024: -89.1%FY 2025: -10.3%
FY 2017 FY 2025
EPS (diluted) -18.2%
FY 2017: 0.0%FY 2018: -7.7%FY 2019: -107.1%FY 2020: 48.3%FY 2021: -133.3%FY 2022: -74.3%FY 2023: -13.1%FY 2024: -75.4%FY 2025: -18.2%
FY 2017 FY 2025
Free Cash Flow -36.4%
FY 2017: 0.0%FY 2018: 4.9%FY 2019: -155.1%FY 2020: -293.1%FY 2021: -272.2%FY 2022: -44.5%FY 2023: -4.5%FY 2024: -12.2%FY 2025: -36.4%
FY 2017 FY 2025

Financial Health

Current Ratio 1.1×
FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 27.4×FY 2021: 70.6×FY 2022: 51.2×FY 2023: 23.7×FY 2024: 1.3×FY 2025: 1.1×
FY 2017 5y median 23.7× FY 2025
Quick Ratio 1.1×
FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 27.4×FY 2021: 70.6×FY 2022: 51.2×FY 2023: 23.7×FY 2024: 1.3×FY 2025: 1.1×
FY 2017 5y median 23.7× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 0.0×FY 2018: 0.1×FY 2019: -0.2×FY 2020: 15.3×FY 2021: 6.0×FY 2022: 1.7×FY 2023: 0.8×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31